• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

354
65
48
46
18

COUNTRY

45
12
5
5
5

PRICE

290
545
1,139
1,425

PUBLISHED

81
132
498
1,425

PRODUCT TYPE

1,329
67
17
12

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2014

Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2014 Summary This, ‘Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2014’, provides an overview of the Primary...

December 2014
FROM
Status Epilepticus - Pipeline Review, H2 2014 Status Epilepticus - Pipeline Review, H2 2014 - Product Thumbnail Image

Status Epilepticus - Pipeline Review, H2 2014

Status Epilepticus - Pipeline Review, H2 2014 Summary This, ‘Status Epilepticus - Pipeline Review, H2 2014’, provides an overview of the Status Epilepticus’s therapeutic pipeline. This report provides...

December 2014
FROM

Hyperalgesia - Pipeline Review, H2 2014

Hyperalgesia - Pipeline Review, H2 2014 Summary This, ‘Hyperalgesia - Pipeline Review, H2 2014’, provides an overview of the Hyperalgesia’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Peripheral Neuropathic Pain - Pipeline Review, H2 2014

Peripheral Neuropathic Pain - Pipeline Review, H2 2014 Summary This, ‘Peripheral Neuropathic Pain - Pipeline Review, H2 2014’, provides an overview of the Peripheral Neuropathic Pain’s therapeutic...

December 2014
FROM
Japanese Encephalitis - Pipeline Review, H2 2014 Japanese Encephalitis - Pipeline Review, H2 2014 - Product Thumbnail Image

Japanese Encephalitis - Pipeline Review, H2 2014

Japanese Encephalitis - Pipeline Review, H2 2014 Summary This, ‘Japanese Encephalitis - Pipeline Review, H2 2014’, provides an overview of the Japanese Encephalitis’s therapeutic pipeline. This report...

December 2014
FROM

Brain Injury - Pipeline Review, H2 2014

Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Brain Injury’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Tauopathies - Pipeline Review, H2 2014

Tauopathies - Pipeline Review, H2 2014 Summary This, ‘Tauopathies - Pipeline Review, H2 2014’, provides an overview of the Tauopathies’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

December 2014
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

December 2014
FROM

Degenerative Disc Disease - Pipeline Review, H2 2014

Degenerative Disc Disease - Pipeline Review, H2 2014 Summary This, ‘Degenerative Disc Disease - Pipeline Review, H2 2014’, provides an overview of the Degenerative Disc Disease’s therapeutic pipeline. This...

November 2014
FROM

Seizures - Pipeline Review, H2 2014

Seizures - Pipeline Review, H2 2014 Summary This, ‘Seizures - Pipeline Review, H2 2014’, provides an overview of the Seizures’s therapeutic pipeline. This report provides comprehensive information...

November 2014
FROM

Anxiety Disorders - Pipeline Review, H2 2014

Anxiety Disorders - Pipeline Review, H2 2014 Summary This, ‘Anxiety Disorders - Pipeline Review, H2 2014’, provides an overview of the Anxiety Disorders’s therapeutic pipeline. This report provides...

November 2014
FROM

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014 Summary This, ‘Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H2 2014’, provides...

November 2014
FROM

Nicotine Addiction - Pipeline Review, H2 2014

Nicotine Addiction - Pipeline Review, H2 2014 Summary This, ‘Nicotine Addiction - Pipeline Review, H2 2014’, provides an overview of the Nicotine Addiction’s therapeutic pipeline. This report provides...

November 2014
FROM

Dementia - Pipeline Review, H2 2014

Dementia - Pipeline Review, H2 2014 Summary This, ‘Dementia - Pipeline Review, H2 2014’, provides an overview of the Dementia’s therapeutic pipeline. This report provides comprehensive information...

November 2014
FROM

Post-Operative Pain - Pipeline Review, H2 2014

Post-Operative Pain - Pipeline Review, H2 2014 Summary This, ‘Post-Operative Pain - Pipeline Review, H2 2014’, provides an overview of the Post-Operative Pain’s therapeutic pipeline. This report...

November 2014
FROM
Moderate Pain - Pipeline Review, H2 2014 Moderate Pain - Pipeline Review, H2 2014 - Product Thumbnail Image

Moderate Pain - Pipeline Review, H2 2014

Moderate Pain - Pipeline Review, H2 2014 Summary This, ‘Moderate Pain - Pipeline Review, H2 2014’, provides an overview of the Moderate Pain’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Intracerebral Hemorrhage - Pipeline Review, H2 2014

Intracerebral Hemorrhage - Pipeline Review, H2 2014 Summary This, ‘Intracerebral Hemorrhage - Pipeline Review, H2 2014’, provides an overview of the Intracerebral Hemorrhage’s therapeutic pipeline. This...

November 2014
FROM

Low Back Pain - Pipeline Review, H2 2014

Low Back Pain - Pipeline Review, H2 2014 Summary This, ‘Low Back Pain - Pipeline Review, H2 2014’, provides an overview of the Low Back Pain’s therapeutic pipeline. This report provides comprehensive...

November 2014
FROM

Obsessive-Compulsive Disorder - Pipeline Review, H2 2014

Obsessive-Compulsive Disorder - Pipeline Review, H2 2014 Summary This, ‘Obsessive-Compulsive Disorder - Pipeline Review, H2 2014’, provides an overview of the Obsessive-Compulsive Disorder’s therapeutic...

November 2014
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.